Solid Biosciences (SLDB)
(Delayed Data from NSDQ)
$5.12 USD
-0.32 (-5.88%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $5.10 -0.02 (-0.39%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SLDB 5.12 -0.32(-5.88%)
Will SLDB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SLDB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SLDB
Wall Street Analysts Believe Solid Biosciences (SLDB) Could Rally 198.18%: Here's is How to Trade
SLDB Stock Rallies 60% in a Month: Here's What You Should Know
SLDB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other News
SLDB Stock Up as FDA Clears IND for SGT-212 in Friedreich's Ataxia
Other News for SLDB
SLDB forms Directional Movement Crossover Bearish on September 19
Is SLDB preparing to trend lower? 20 Day Moving Average Resistance shows up after declining 0.55%
Is SLDB likely to continue lower? 20 Day Moving Average Resistance shows up after gaining 1.11%
H.C. Wainwright Remains a Buy on Solid Biosciences (SLDB)
Is SLDB poised for gains? MACD Bullish Signal Line Cross shows up after declining 1.46%